Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$47.5M |
| 2 |
Johnson & Johnson
JNJ
|
+$34.9M |
| 3 |
Phillips 66
PSX
|
+$34.7M |
| 4 |
Chevron
CVX
|
+$31.9M |
| 5 |
Johnson Controls International
JCI
|
+$31.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
COUP
Coupa Software Incorporated
COUP
|
+$51.8M |
| 2 |
COWN
Cowen Inc. Class A Common Stock
COWN
|
+$49.5M |
| 3 |
EVOP
EVO Payments, Inc. Class A Common Stock
EVOP
|
+$48.2M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
+$37.7M |
| 5 |
STOR
STORE Capital Corporation
STOR
|
+$23.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.69% |
| 2 | Industrials | 11.81% |
| 3 | Healthcare | 11.19% |
| 4 | Financials | 10.02% |
| 5 | Consumer Discretionary | 9.43% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CLVT.PRA
1501
DELISTED
Clarivate Plc 5.25% Series A Mandatory Convertible Preferred Shares
CLVT.PRA
| $616K | 0.01% |
15,000
| – | – |
|
1502
Viridian Therapeutics
VRDN
$2.72B
| $613K | 0.01% |
+24,110
| New | +$773K |
|
1503
NETGEAR
NTGR
$563M
| $611K | 0.01% |
33,019
-10,270
| -24% | -$193K |
|
1504
PUT
Gaming and Leisure Properties
GLPI
$12.8B
| $610K | 0.01% |
+11,700
| New | +$611K |
|
1505
PUT
Illinois Tool Works
ITW
$80.9B
| $609K | 0.01% |
2,500
-100
| -4% | -$23.3K |
|
1506
CALL
Rambus
RMBS
$9.44B
| $609K | 0.01% |
+11,900
| New | +$511K |
|
1507
CALL
Quest Diagnostics
DGX
$26.9B
| $608K | 0.01% |
4,300
-400
| -9% | -$57.2K |
|
1508
Hingham Institution for Saving
HIFS
$668M
| $608K | 0.01% |
+2,604
| New | +$715K |
|
1509
Chemed
CHE
$7.08B
| $607K | 0.01% |
+1,129
| New | +$576K |
|
1510
CALL
Essex Property Trust
ESS
$18.9B
| $607K | 0.01% |
2,900
-500
| -15% | -$110K |
|
1511
CALL
Paycom
PAYC
$10.3B
| $607K | 0.01% |
+2,000
| New | +$602K |
|
1512
CALL
Zimmer Biomet
ZBH
$19.3B
| $607K | 0.01% |
+4,700
| New | +$590K |
|
|
BELFB
1513
Bel Fuse Inc Class B
BELFB
$3.58B
| $602K | 0.01% |
+16,008
| New | +$576K |
|
1514
Amphastar Pharmaceuticals
AMPH
$915M
| $600K | 0.01% |
+16,010
| New | +$525K |
|
1515
Malibu Boats
MBUU
$579M
| $600K | 0.01% |
10,636
-22,630
| -68% | -$1.32M |
|
1516
Consolidated Edison
ED
$39.8B
| $598K | 0.01% |
6,255
-38,593
| -86% | -$3.61M |
|
1517
Equinor
EQNR
$101B
| $598K | 0.01% |
+21,036
| New | +$635K |
|
1518
CALL
Freeport-McMoran
FCX
$112B
| $597K | 0.01% |
+14,600
| New | +$607K |
|
|
WBA
1519
CALL
DELISTED
Walgreens Boots Alliance
WBA
| $597K | 0.01% |
17,300
-69,600
| -80% | -$2.47M |
|
1520
CALL
Whirlpool
WHR
$2.62B
| $594K | 0.01% |
4,500
-4,200
| -48% | -$598K |
|
1521
CALL
On Holding
ONON
$9.86B
| $593K | 0.01% |
19,100
+300
| +2% | +$6.79K |
|
|
1522
Freeport-McMoran
FCX
$112B
| $592K | 0.01% |
14,475
-180,828
| -93% | -$7.52M |
|
|
ELME
1523
Elme Communities
ELME
$149M
| $588K | 0.01% |
+32,905
| New | +$602K |
|
1524
Karyopharm Therapeutics
KPTI
$42.2M
| $588K | 0.01% |
10,082
+2,098
| +26% | +$104K |
|
|
1525
PUT
Phillips 66
PSX
$96.5B
| $587K | 0.01% |
5,800
-6,600
| -53% | -$671K |
|
Similar funds
Paul Tudor Jones's Q1 2023 Portfolio in Review
As of Q1 2023, Paul Tudor Jones held 3,136 positions worth $6.46B, up 28% from $5.06B the previous quarter. Its ten largest holdings account for 6.8% of the portfolio.
Paul Tudor Jones deployed $1.28B of net new capital in Q1 2023, opening 836 new positions and adding to 737 existing holdings. Its largest new stake was Johnson & Johnson: 216,183 shares worth $33.5M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 16% a quarter earlier, followed by Industrials and Healthcare.
On the sell side, the largest reduction was iShares MSCI Emerging Markets ETF, an estimated $37.7M trimmed.
- Paul Tudor Jones's largest Q1 2023 buy was Johnson & Johnson: 216,183 shares worth $33.5M.
- Paul Tudor Jones added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2023, an estimated $47.5M increase.
- Paul Tudor Jones's biggest Q1 2023 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $37.7M.
- Paul Tudor Jones fully exited Coupa Software Incorporated in Q1 2023, selling an estimated $51.8M.
- Paul Tudor Jones's ten largest holdings make up 6.8% of its $6.46B portfolio in Q1 2023.
- Paul Tudor Jones opened 836 new positions and closed 800 in Q1 2023.
- Paul Tudor Jones's portfolio value rose 28% quarter-over-quarter to $6.46B.
Based on Tudor Investment Corp's 13F filing for Q1 2023, filed 15 May 2023.